menu
    • menu

    Company profile for Entrada Therapeutics

    NEW Drugs in Dev: 3
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Entrada, we value intellectual curiosity and enjoy the challenge of fighting the good fight: waking up each day to advance our science one step closer to helping patients and their caregivers who deserve better treatments. Entrada’s Endosomal Escape Vehicle (EEV™) technology represents a fundamental advancement to the design and development of intracellular biologics. Our therapeutic candidates exhibit high cellular upt...
    At Entrada, we value intellectual curiosity and enjoy the challenge of fighting the good fight: waking up each day to advance our science one step closer to helping patients and their caregivers who deserve better treatments. Entrada’s Endosomal Escape Vehicle (EEV™) technology represents a fundamental advancement to the design and development of intracellular biologics. Our therapeutic candidates exhibit high cellular uptake, achieve highly efficient endosomal escape and are designed to be exquisitely specific to intracellular targets.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Entrada TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    6 Tide Street Boston, MA 02210
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.entradatx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Entrada's Stock Plummets As Duchenne Drug Misses Expectations
    Entrada's Stock Plummets As Duchenne Drug Misses Expectations

    07 May 2026

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/entradas-duchenne-drug-shown-improve-muscle-function-early-trial-2026-05-07/

    REUTERS
    07 May 2026
    Share Share
    Entrada to Report Phase 1/2 ENTR-601-44 DMD Data May 7
    Entrada to Report Phase 1/2 ENTR-601-44 DMD Data May 7

    06 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/06/3289417/0/en/entrada-therapeutics-to-announce-topline-results-from-cohort-1-of-participants-with-duchenne-muscular-dystrophy-treated-with-entr-601-44-in-phase-1-2-elevate-44-201-study-on-may-7-.html

    GLOBENEWSWIRE
    06 May 2026
    Share Share
    Entrada Therapeutics Announces Nasdaq Inducement Grants
    Entrada Therapeutics Announces Nasdaq Inducement Grants

    02 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/02/3247889/0/en/Entrada-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    02 Mar 2026
    Share Share
    IDMC Recommends Cohort 2 12 mg/kg In ELEVATE-44-201 Trial
    IDMC Recommends Cohort 2 12 mg/kg In ELEVATE-44-201 Trial

    17 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/17/3239084/0/en/Independent-Data-Monitoring-Committee-Recommends-Initiation-of-Cohort-2-at-the-Increased-Dose-of-12-mg-kg-in-Entrada-Therapeutics-ELEVATE-44-201-Study.html

    GLOBENEWSWIRE
    17 Feb 2026
    Share Share
    Entrada Therapeutics To Present At Upcoming Investor Conferences
    Entrada Therapeutics To Present At Upcoming Investor Conferences

    04 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/04/3231902/0/en/Entrada-Therapeutics-to-Present-at-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    04 Feb 2026
    Share Share
    Entrada Therapeutics Advances Rna-Based Therapeutics
    Entrada Therapeutics Advances Rna-Based Therapeutics

    08 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/08/3215189/0/en/Entrada-Therapeutics-Highlights-Progress-Across-its-Portfolio-of-RNA-based-Therapeutics-for-the-Treatment-of-Neuromuscular-and-Ocular-Diseases.html

    GLOBENEWSWIRE
    08 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search